Report Details:
15 Companies Covered
128 Pages
Central Venous Catheter Market Highlights
The Central Venous Catheter Market was valued at USD 2.71 Billion in 2025 and is projected to reach USD 2.88 Billion in 2026, expanding to USD 5.23 Billion by 2035 at a CAGR of 6.85% over the forecast period.
A rising number of people are developing chronic illnesses, which is driving the central venous catheter market's CAGR. Central venous catheters (CVCs) are widely used in modern healthcare due in large part to the rising incidence of chronic illnesses, especially cancer and cardiovascular diseases.
These catheters are necessary to deliver efficient, continuous care to patients with these challenging conditions. For patients undergoing long-term care, CVCs are essential because they simplify the administration of critical medications, blood transfusions, and fluid therapy.
As the worldwide burden of chronic diseases increases, so does the need for central venous catheters in providing precise and continuous medical interventions. This underscores the catheters' critical role in enhancing patient care and treatment outcomes in the face of challenging medical circumstances.
MRFR recognizes the following companies as the key players in the global Central Venous Catheter market— Amecath, B. Braun Melsungen AG, Boston Scientific Corporation, AngioDynamics, Inc., BACTIGUARD, Cook Medical, Inc., Smiths Medical, Becton, Dickinson & Company, Biosensors International Group Ltd., BARD Care, ConMed Corporation, Edwards Lifesciences Corporation, and Coloplast.
Segment Analysis
The global Central Venous Catheter market has been segmented based on Product Type, Property, Design, and Compositions
Based on Product Type, the global Central Venous Catheter market has been segmented into Non-tunneled Catheters and tunneled Catheters. The Non-tunneled Catheters segment was expected to hold the largest market share in 2024. The overall growth of this segment is being driven by the rise in incisions worldwide and the increasing recognition of the need to use non-tunneled catheters during emergencies.
Based on Property, the global Central Venous Catheter market has been segmented into Antimicrobial Catheters, Non-Antimicrobial Catheters, and Others. The Antimicrobial Catheters segment was anticipated to hold the major market share in 2024. A worldwide focus on preventing HAIs (Healthcare-Associated Infections) is driving market expansion in this region.
Based on Design, the global Central Venous Catheter market has been segmented into Multi Lumen, Double Lumen, and Single Lumen. The double-lumen segment was expected to hold the biggest market share in 2024. The increase in ICU treatments for ARF (acute renal failure) is driving the growth of the market overall in this region.
Based on Compositions, the global Central Venous Catheter market has been segmented into Polyurethane, Silicone, and Others. The Silicon segment was anticipated to hold the major market share in 2024. Due to their flexibility and extended lifespan when used as tunneled central venous catheters (CVCs), silicone catheters are the recommended choice across the globe.
Regional Analysis
The global Central Venous Catheter market, based on region, has been divided into the North America, Europe, Asia-Pacific, and Rest of the World. North America consists of US and Canada. The Europe Central Venous Catheter market comprises of Germany, France, the UK, Italy, Spain, and the rest of Europe.
The Central Venous Catheter market in Asia-Pacific has been segmented into China, India, Japan, Australia, South Korea, and the rest of Asia-Pacific. The Rest of the World's Central Venous Catheter market comprises of Middle East, Africa, and Latin America.
The largest market share for Central Venous Catheters was maintained by the North American regional sector. This is because the area has a high prevalence of chronic diseases like cancer and kidney issues, prominent people live there, and the number of critically ill patients is rising.
Moreover, the Europe market has been persistently growing over the forecast period. The aging population's rising need for sophisticated medical treatments, such as CVCs for chronic illnesses like cancer and heart disease, is driving the market.
Additionally, the Asia-Pacific Central Venous Catheter Market is anticipated to expand at the quickest rate. The high frequency of chronic illnesses, the increase in affordability, and the expansion of healthcare access in developing countries are the main drivers of the market's growth in the region. Furthermore, in the Asia-Pacific area, the Indian Central Venous Catheter market was expanding at the fastest rate, while China's market had the biggest market share.
Furthermore, the rest of the world's Central Venous Catheter market is divided into the Middle East, Africa, and Latin America. This growth is attributed to the growing prevalence of chronic diseases and the expanding number of surgical interventions.
Key Findings of the Study
- Fluid and nutrition administration is the fastest-growing application at a 10.4% CAGR, supported by home parenteral nutrition
- Diagnostics and testing contributes USD 0.29 billion in 2025
- North America accounts for a 39.6% share, led by U.S. dialysis and oncology volumes
- Asia-Pacific records an 8.9% CAGR through 2035 on hospital capacity expansion in China and India
- Europe holds a 27.4% share under harmonized infection-prevention protocols
